Nancy Wysenski Insider Trading $ALKS Alkermes plc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy Wysenski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy Wysenski. Nancy Wysenski is Director in NORTH AMERICAN SCIENTIFIC INC ($NASI) and Director in INOVIO PHARMACEUTICALS, INC. ($GEB) and Director in CYTOKINETICS INC ($CYTK) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in Alkermes plc. ($ALKS) and Director in Dova Pharmaceuticals, Inc. ($DOVA) and Director in Provention Bio, Inc. ($PRVB).
Nancy Wysenski in Alkermes plc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nancy Wysenski: Director
Holdings: 11,242 shares
Current Value: $615,724
Latest Transaction: Dec 04 2020
$ALKS Market Capitalization: $8.28B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nancy Wysenski in Alkermes plc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALKS, CYTK, DOVA, GEB, NASI, PRVB, TTPH
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 04 2020 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 5,578 | |
| Dec 04 2020 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 0.00 | 5,578 | 0 | 5,578 | |
| Dec 04 2020 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 18.82 | 11,509 | 216,599 | 11,509 | |
| Dec 04 2020 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 18.82 | 11,509 | 216,599 | 11,509 | |
| Feb 25 2020 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Buy | P | 19.65 | 6,940 | 136,371 | 11,242 | 4.3 K to 11.2 K (+161.32 %) |
| May 23 2019 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 25.04 | 22,400 | 560,896 | 22,400 | |
| Mar 18 2019 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Buy | P | 33.06 | 445 | 14,712 | 4,302 | 3.9 K to 4.3 K (+11.54 %) |
| Mar 18 2019 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Buy | P | 33.09 | 3,857 | 127,628 | 3,857 | 0 to 3.9 K |
| May 24 2018 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 45.64 | 17,500 | 798,700 | 17,500 | |
| May 25 2017 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 58.25 | 14,200 | 827,150 | 14,200 | |
| May 26 2016 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 43.58 | 21,600 | 941,328 | 21,600 | |
| May 29 2015 | ALKS | Alkermes plc. | Wysenski Nancy | Director | Option Exercise | A | 60.57 | 16,000 | 969,120 | 16,000 |
Page: 1